Amino acid prices show varying trends as markets shift into a quieter, contract-heavy period. While methionine prices soar on supply constraints, lysine, threonine, tryptophan, and valine show signs of stability or limited movement amid subdued demand.
In partnership with Feed Additive Prices
Lysine
Prices, FOB China and in other regions, have levelled off since last week and are even beginning to show some first signs of decline. Suppliers are keen to uphold the current elevated prices, and some even aim to push them higher. However, with a lack of new demand and buyers already contracted for the upcoming months, a cautious wait-and-see approach has taken hold. Q2 and a substantial portion of Q3 are already secured through contracts.
Threonine
The prices of threonine continue to rise gradually with suppliers showing eagerness to implement further increases. However, sustaining this momentum proves challenging due to a lack of new demand, leaving the market relatively quiet and well contracted for the future. Anticipation grows as more production capacity is expected to enter the market later this year. Buying activity has diminished in recent weeks, with a significant portion of the second and third quarters already contracted, leading to a quieter market compared to previous weeks.
DL-Methionine
Prices continue to climb due to the petrochemical-related supply chain being heavily influenced by the ongoing situation in Iran. And with all suppliers reporting supply challenges coupled with planned plant maintenance, the current and foreseeable availability remains quite limited. Some suppliers briefly explored offers for Q3 deliveries, but they quickly withdrew from those opportunities. Prices have doubled in Europe and Asia, and increases are now also being observed in the USA. Q2 is contracted, but a significant portion of Q3 is still wide open.
Tryptophan
While there hasn’t been much change compared to previous weeks, prices remain elevated compared to some months ago, and the overall market sentiment is stable to firm. Similar to trends observed with other amino acids, buyers have effectively secured their upcoming needs, resulting in a noticeable absence of new demand at this time. Contracts for Q2 and a substantial portion of Q3 are already in place.
Valine
After a period of firm prices, the market in several regions now appears to have found some stability, bringing a sense of calm. However, when it comes to nearby deliveries, availability continues to be a challenge as suppliers remain tight on supply. On a brighter note, looking ahead to late Q2 and Q3, there are signs of potential relief.
